Thomas Thisted

Thomas Thisted has worked in the biotechnology field since 1995. Thomas began their career as a Postdoctoral Fellow at the Howard Hughes Medical Institute at the University of Pennsylvania in Philadelphia. Thomas then moved to the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey as a Postdoctoral Fellow. In 2000, they began working as a Research Scientist at Novozymes. Thomas then moved to Nuevolution as a Senior Scientist in 2002. In 2008, they began working at MedImmune as a Senior Scientist. In 2015, they moved to Antidote Therapeutics, Inc. as a Senior Scientist. Thomas then moved to Sensei Bio in 2018, where they have held the roles of Director of Biologics Discovery & Early Development, Associate Director, and Senior Scientist.

Thomas Thisted received their Ph.D. in Molecular Biology from Syddansk Universitet - University of Southern Denmark in 1994.